FDG-PET/CT Response and Prediction of Pathological Response to Neoadjuvant Nivolumab and Ipilimumab for Clinical Stage III Melanoma
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined